Impact of 12 weeks oral niacin on endothelial function, lipid composition and cardiovascular biomarkers in patients with coronary artery disease: a prospective, randomized, double-blind, placebo-controlled, monocentric clinical trial of phase IV

http://isrctn.org/> ◽

10.1186/isrctn48365122 ◽

2013 ◽

Author(s):

Ascan Warnholtz

Keyword(s):

Coronary Artery Disease ◽

Clinical Trial ◽

Coronary Artery ◽

Endothelial Function ◽

Lipid Composition ◽

Double Blind ◽

Double Blind Placebo ◽

Artery Disease ◽

Cardiovascular Biomarkers ◽

Download Full-text

Effect of 8 weeks oral pentaerithrityltetranitrate on endothelial dysfunction in patients with coronary artery disease: a prospective, randomized, double-blind, placebo-controlled, monocentric clinical trial of phase IV

http://isrctn.org/> ◽

10.1186/isrctn14741769 ◽

2013 ◽

Author(s):

Ascan Warnholtz

Keyword(s):

Coronary Artery Disease ◽

Clinical Trial ◽

Coronary Artery ◽

Endothelial Dysfunction ◽

Double Blind ◽

Double Blind Placebo ◽

Artery Disease ◽

Download Full-text

Effect of Probiotic Supplementation along with Calorie Restriction on Metabolic Endotoxemia, Trimethylamine-N-Oxide, Inflammation, Metabolic Factors, and Gut Microbiota Profile in Coronary Artery Disease Patients: A Double Blind Placebo Controlled Randomized Clinical Trial

10.21203/rs.3.rs-17854/v2 ◽

2020 ◽

Author(s):

Jalal Moludi ◽

Hossein Samadi Kafil ◽

Pouria Gholizadeh ◽

Mohammad Alizadeh

Keyword(s):

Coronary Artery Disease ◽

Clinical Trial ◽

Coronary Artery ◽

Gut Microbiota ◽

Metabolic Factors ◽

Probiotic Supplementation ◽

Double Blind ◽

Double Blind Placebo ◽

Artery Disease ◽

Metabolic Endotoxemia

Abstract The authors have requested that this preprint be withdrawn due to author disagreement.

Download Full-text

Effects of Nigella sativa oil supplementation on selected metabolic parameters and anthropometric indices in patients with coronary artery disease: A randomized, double‐blind, placebo‐controlled clinical trial

Phytotherapy Research ◽

10.1002/ptr.7115 ◽

2021 ◽

Author(s):

Omid Mohammad Tavakoli‐Rouzbehani ◽

Mohsen Abbasnezhad ◽

Sorayya Kheirouri ◽

Mohammad Alizadeh

Keyword(s):

Coronary Artery Disease ◽

Clinical Trial ◽

Coronary Artery ◽

Nigella Sativa ◽

Controlled Clinical Trial ◽

Anthropometric Indices ◽

Double Blind ◽

Double Blind Placebo ◽

Nigella Sativa Oil ◽

Download Full-text

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

ACC Current Journal Review ◽

10.1016/s1062-1458(01)00465-2 ◽

2001 ◽

Vol 10 (6) ◽

pp. 31-32

Author(s):

J Thambyrajah ◽

M.J Landray ◽

H.J Jones ◽

F.J McGlynn ◽

D.C Wheeler ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Endothelial Function ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Therapy ◽

Download Full-text

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(01)01235-9 ◽

2001 ◽

Vol 37 (7) ◽

pp. 1858-1863 ◽

Author(s):

Jeetendra Thambyrajah ◽

Martin J Landray ◽

Heather J Jones ◽

Fiona J McGlynn ◽

David C Wheeler ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Endothelial Function ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Therapy ◽

Download Full-text

Comparison of Antiplatelet Effect and Safety of Clopidogrel Napadisilate with Clopidogrel Bisulfate in Coronary Artery Disease Patients: Multi-center, Randomized, Double-blind, Phase IV, Non-inferiority Clinical Trial

American Journal of Cardiovascular Drugs ◽

10.1007/s40256-013-0039-y ◽

2013 ◽

Vol 13 (6) ◽

pp. 413-424 ◽

Author(s):

Sahmin Lee ◽

Hae-Young Lee ◽

Kyung-Woo Park ◽

Hyun-Jae Kang ◽

Bon-Kwon Koo ◽

...

Keyword(s):

Coronary Artery Disease ◽

Clinical Trial ◽

Coronary Artery ◽

Double Blind ◽

Antiplatelet Effect ◽

Clopidogrel Bisulfate ◽

Artery Disease ◽

Download Full-text

Exploring the potential of low-dose sulfasalazine in stable coronary artery disease patients: randomized, double-blind, placebo-controlled study

European Heart Journal - Cardiovascular Pharmacotherapy ◽

10.1093/ehjcvp/pvv021 ◽

2015 ◽

Vol 1 (4) ◽

pp. 214-216 ◽

Author(s):

Kanchan Vohra ◽

Pawan Krishan ◽

Sudhir Varma ◽

Harpreet Singh Kalra

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Low Dose ◽

Stable Coronary Artery Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial

Yearbook of Urology ◽

10.1016/s0084-4071(08)79154-1 ◽

2008 ◽

Vol 2008 ◽

pp. 193-195

Author(s):

A. Shindel

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Crossover Trial ◽

Sildenafil Citrate ◽

Intravenous Nitroglycerin ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized Crossover Trial ◽

Download Full-text

Effect of Ioxaglate on the cutaneous microcirculation in patients with coronary artery disease: Randomized, double blind, placebo-controlled study

Clinical Hemorheology and Microcirculation ◽

10.3233/ch-168101 ◽

2017 ◽

Vol 64 (3) ◽

pp. 297-304 ◽

Author(s):

U. Gerk ◽

C. Mrowietz ◽

R. Sternitzky ◽

R.P. Franke ◽

S.G. Spitzer ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Cutaneous Microcirculation ◽

Download Full-text

Magnesium Sulfate Administration in Moderate Coronary Artery Disease Patients Improves Atherosclerotic Risk Factors: A Double-Blind Clinical Trial Study

Journal of Cardiovascular Pharmacology ◽

10.1097/fjc.0000000000000874 ◽

2020 ◽

Vol 76 (3) ◽

pp. 321-328

Author(s):

Hossein Farshidi ◽

Ali R. Sobhani ◽

Mahdiye Eslami ◽

Fariba Azarkish ◽

Ebrahim Eftekhar ◽

...

Keyword(s):

Risk Factors ◽

Coronary Artery Disease ◽

Clinical Trial ◽

Coronary Artery ◽

Magnesium Sulfate ◽

Double Blind ◽

Double Blind Clinical Trial ◽

Artery Disease ◽

Atherosclerotic Risk Factors

Download Full-text